{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:02:23Z","timestamp":1791414143794,"version":"4.3.3"},"reference-count":74,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T00:00:00Z","timestamp":1374710400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0068917","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T22:30:23Z","timestamp":1374791423000},"page":"e68917","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["In Vitro Characterization of the Anti-Bacterial Activity of SQ109 against Helicobacter pylori"],"prefix":"10.1371","volume":"8","author":[{"given":"Morris O.","family":"Makobongo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo","family":"Einck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Peek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Scott","family":"Merrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,7,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/oxfordjournals.epirev.a018040","article-title":"<italic>Helicobacter pylori<\/italic>: epidemiology and routes of transmission","volume":"22","author":"LM Brown","year":"2000","journal-title":"Epidemiol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/515663","article-title":"A community-based seroepidemiologic study of <italic>Helicobacter pylori<\/italic> infection in Mexico","volume":"178","author":"J Torres","year":"1998","journal-title":"J Infect Dis"},{"key":"ref3","first-page":"1327","article-title":"Management of <italic>Helicobacter pylori<\/italic> infection","volume":"65","author":"LN Meurer","year":"2002","journal-title":"Am Fam Physician"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1136\/gut.32.11.1415","article-title":"Acute <italic>Helicobacter pylori<\/italic> infection: clinical features, local and systemic immune response, gastric mucosal histology, and gastric juice ascorbic acid concentrations","volume":"32","author":"GM Sobala","year":"1991","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","article-title":"<italic>Helicobacter pylori<\/italic> infection","volume":"347","author":"S Suerbaum","year":"2002","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3109\/00365529309098288","article-title":"Treatment of <italic>Helicobacter pylori<\/italic> reduces the rate of rebleeding in peptic ulcer disease","volume":"28","author":"DY Graham","year":"1993","journal-title":"Scand J Gastroenterol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1572-0241.1998.00333.x","article-title":"The impact of <italic>Helicobacter pylori<\/italic> eradication on peptic ulcer healing","volume":"93","author":"G Treiber","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"ref8","article-title":"Efficacy of sitafloxacin-based rescue therapy for <italic>Helicobacter pylori<\/italic> after failures of first- and second-line therapies. Antimicrob Agents Chemother","author":"J Matsuzaki","year":"2011"},{"key":"ref9","first-page":"89","article-title":"Rescue therapy after <italic>Helicobacter pylori<\/italic> eradication failure","volume":"34","author":"JP Gisbert","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1111\/j.1572-0241.2006.00684_1.x","article-title":"Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment","volume":"101","author":"T Rokkas","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"5385","DOI":"10.3748\/wjg.14.5385","article-title":"&quot;Rescue&quot; regimens after <italic>Helicobacter pylori<\/italic> treatment failure","volume":"14","author":"JP Gisbert","year":"2008","journal-title":"World J Gastroenterol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/gut.2003.022111","article-title":"<italic>H. pylori<\/italic> antibiotic resistance: prevalence, importance, and advances in testing","volume":"53","author":"F M\u00e9graud","year":"2004","journal-title":"Gut"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00001574-200201000-00005","article-title":"<italic>Helicobacter pylori<\/italic> infection: treatment","volume":"18","author":"L Belhoussine-Idrissi","year":"2002","journal-title":"Curr Opin Gastroenterol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","article-title":"Current concepts in the management of <italic>Helicobacter pylori<\/italic> infection: the Maastricht III Consensus Report","volume":"56","author":"P Malfertheiner","year":"2007","journal-title":"Gut"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.mib.2003.08.003","article-title":"Why is big Pharma getting out of antibacterial drug discovery?","volume":"6","author":"SJ Projan","year":"2003","journal-title":"Curr Opin Microbiol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/431899a","article-title":"Antibiotics at the crossroads","volume":"431","author":"C Nathan","year":"2004","journal-title":"Nature"},{"key":"ref17","article-title":"The crisis of no new antibiotics-what is the way forward?","author":"LJ Piddock","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/nbt1265","article-title":"Molecular engineering approaches to peptide, polyketide and other antibiotics","volume":"24","author":"RH Baltz","year":"2006","journal-title":"Nat Biotechnol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for bad bugs: confronting the challenges of antibacterial discovery","volume":"6","author":"DJ Payne","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1046\/j.1469-0691.2001.00060.x","article-title":"The oxazolidinones as a new family of antimicrobial agent","volume":"7","author":"A Marchese","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00003495-200059010-00002","article-title":"Oxazolidinones: a review","volume":"59","author":"DI Diekema","year":"2000","journal-title":"Drugs"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.chembiol.2004.12.009","article-title":"Chimeric streptogramin-tyrocidine antibiotics that overcome streptogramin resistance","volume":"12","author":"TA Mukhtar","year":"2005","journal-title":"Chem Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1021\/cr030110z","article-title":"Streptogramins, oxazolidinones, and other inhibitors of bacterial protein synthesis","volume":"105","author":"TA Mukhtar","year":"2005","journal-title":"Chem Rev"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/jac\/dki319","article-title":"Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines","volume":"56","author":"M Protopopova","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.bjp.0705984","article-title":"Pharmacodynamics and pharmacokinetics of SQ109, a new diamine-based antitubercular drug","volume":"144","author":"L Jia","year":"2005","journal-title":"Br J Pharmacol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/jac\/dkl227","article-title":"Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs <italic>in vitro<\/italic>","volume":"58","author":"P Chen","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1128\/AAC.01326-06","article-title":"Drug therapy of experimental tuberculosis (TB): improved outcome by combining SQ109, a new diamine antibiotic, with existing TB drugs","volume":"51","author":"BV Nikonenko","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref28","article-title":"Phase 1 safety and pharmacokinetics of SQ109, a new diamine antituberculosis drug","author":"G Horwith","year":"2007"},{"key":"ref29","year":"2010"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/sj.bjp.0706650","article-title":"Interspecies pharmacokinetics and <italic>in vitro<\/italic> metabolism of SQ109","volume":"147","author":"L Jia","year":"2006","journal-title":"Br J Pharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1128\/AAC.00510-09","article-title":"<italic>In vitro<\/italic> antibacterial activity of acyl-lysyl oligomers against <italic>Helicobacter pylori<\/italic>","volume":"53","author":"MO Makobongo","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref32","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.05708-11","article-title":"SQ109 Targets MmpL3 a membrane transporter of trehalose tonomycolate involved in mycolic acid donation to the cell wall core of <italic>Mycobacterium tuberculosis<\/italic>","volume":"56","author":"K Tahlan","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1128\/AAC.00689-11","article-title":"The oligo-acyl lysyl antimicrobial peptide C<sub>12<\/sub>K-2\u03b2 12 exhibits a dual mechanism of action and demonstrates strong <italic>in vivo<\/italic> efficacy against <italic>Helicobacter pylori<\/italic>","volume":"56","author":"MO Makobongo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"12619","DOI":"10.1073\/pnas.95.21.12619","article-title":"Free recombination within <italic>Helicobacter pylori<\/italic>","volume":"95","author":"S Suerbaum","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"14607","DOI":"10.1073\/pnas.241517298","article-title":"Mutation frequency and biological cost of antibiotic resistance in <italic>Helicobacter pylori<\/italic>","volume":"98","author":"B Bj\u00f6rkholm","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1128\/AAC.36.1.185","article-title":"Bactericidal activity of antimicrobial agents against slowly growing <italic>Helicobacter pylori<\/italic>","volume":"36","author":"MR Millar","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e5349","DOI":"10.1371\/journal.pone.0005349","article-title":"The genetic requirements for fast and slow growth in mycobacteria","volume":"4","author":"DJ Beste","year":"2009","journal-title":"PLOS ONE"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/AAC.26.4.546","article-title":"Use of the fluorescent probe 1-N-phenylnaphthylamine to study the interactions of aminoglycoside antibiotics with the outer membrane of <italic>Pseudomonas aeruginosa<\/italic>","volume":"26","author":"B Loh","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1128\/AAC.26.1.48","article-title":"Compounds which increase the permeability of the <italic>Pseudomonas aeruginosa<\/italic> outer membrane","volume":"26","author":"RE Hancock","year":"1984","journal-title":"Antimicrob Agents Chemother"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-0711-4-1","article-title":"<italic>Helicobacter pylori<\/italic> and gastroduodenal pathology: new threats of the old friend","volume":"4","author":"N Ahmed","year":"2005","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.3748\/wjg.v17.i35.3971","article-title":"A new look at anti-<italic>Helicobacter pylori<\/italic> therapy","volume":"17","author":"SK Chuah","year":"2011","journal-title":"World J Gastroenterol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1523-5378.2011.00896.x","article-title":"A Comparison between sequential therapy and a modified bismuth-based quadruple therapy for <italic>Helicobacter pylori<\/italic> eradication in Iran: A randomized clinical trial","volume":"17","author":"H Fakheri","year":"2012","journal-title":"Helicobacter"},{"key":"ref43","article-title":"Ten-day sequential therapy is more effective than proton-pump inhibitor-based therapy in Korea: a prospective randomized study","author":"HS Oh","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2036.2011.04902.x","article-title":"Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for <italic>Helicobacter pylori<\/italic> infection in naive patients","volume":"35","author":"HG Park","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"ref45","first-page":"351","article-title":"Update on <italic>Helicobacter pylori<\/italic> treatment","volume":"75","author":"AZ Ables","year":"2007","journal-title":"Am Fam Physician"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/00365529309098341","article-title":"Compliance, adverse events and antibiotic resistance in <italic>Helicobacter pylori<\/italic> treatment","volume":"196","author":"P Malfertheiner","year":"1993","journal-title":"Scand J Gastroenterol Suppl"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1046\/j.1462-5822.2002.00222.x","article-title":"<italic>Helicobacter pylori<\/italic> enter and survive within multivesicular vacuoles of epithelial cells","volume":"4","author":"MR Amieva","year":"2002","journal-title":"Cell Microbiol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1086\/368133","article-title":"Intracellular and interstitial expression of <italic>Helicobacter pylori<\/italic> virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma","volume":"187","author":"C Semino-Mora","year":"2003","journal-title":"J Infect Dis"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1053\/j.gastro.2007.01.068","article-title":"Intracellular <italic>Helicobacter pylori<\/italic> and gastric carcinogenesis: an &quot;old&quot; frontier worth revisiting","volume":"132","author":"A Dubois","year":"2007","journal-title":"Gastroenterology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1572-0241.2001.03788.x","article-title":"Retreatment of <italic>Helicobacter pylori<\/italic> infection after initial treatment failure","volume":"96","author":"DJ Kearney","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1572-0241.2007.01500.x","article-title":"Second-line rescue therapy with levofloxacin after <italic>H. pylori<\/italic> treatment failure: a Spanish multicenter study of 300 patients","volume":"103","author":"JP Gisbert","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1128\/AAC.00749-08","article-title":"New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development","volume":"53","author":"J van den Boogaard","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0213-005X(11)70018-0","article-title":"New drugs for tuberculosis treatment","volume":"29","author":"F S\u00e1nchez","year":"2011","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1124\/jpet.105.087817","article-title":"Pharmacoproteomic effects of isoniazid, ethambutol, and N-geranyl-N&apos;-(2-adamantyl)ethane-1,2-diamine (SQ109) on <italic>Mycobacterium tuberculosis<\/italic> H37Rv","volume":"315","author":"L Jia","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0732-8893(95)00094-Q","article-title":"<italic>In vitro<\/italic> killing of penicillin-susceptible, -intermediate, and -resistant strains of <italic>Streptococcus pneumoniae<\/italic> by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels","volume":"22","author":"CW Stratton","year":"1995","journal-title":"Diagn Microbiol Infect Dis"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1128\/JCM.37.8.2740-2741.1999","article-title":"Stable and unstable amoxicillin resistance in <italic>Helicobacter pylori<\/italic>: should antibiotic resistance testing be performed prior to eradication therapy?","volume":"37","author":"SR Han","year":"1999","journal-title":"J Clin Microbiol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1128\/AAC.48.12.4843-4847.2004","article-title":"Distribution of antibiotic MICs for <italic>Helicobacter pylori<\/italic> strains over a 16-year period in patients from Seoul, South Korea","volume":"48","author":"JM Kim","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1021\/cc020071p","article-title":"Combinatorial lead optimization of [1,2]-diamines based on ethambutol as potential antituberculosis preclinical candidates","volume":"5","author":"RE Lee","year":"2003","journal-title":"J Comb Chem"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/1753465808099522","article-title":"Managing TB in the 21st century: existing and novel drug therapies","volume":"2","author":"ES Guy","year":"2008","journal-title":"Ther Adv Respir Dis"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1096\/fj.07-105015","article-title":"Analogous oligo-acyl-lysines with distinct antibacterial mechanisms","volume":"22","author":"S Rotem","year":"2008","journal-title":"FASEB J"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"11033","DOI":"10.1073\/pnas.0600829103","article-title":"Imaging peptidoglycan biosynthesis in <italic>Bacillus subtilis<\/italic> with fluorescent antibiotics","volume":"103","author":"K Tiyanont","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1128\/JB.01311-09","article-title":"MreB drives <italic>de novo<\/italic> rod morphogenesis in <italic>Caulobacter crescentus<\/italic> via remodeling of the cell wall","volume":"192","author":"CN Takacs","year":"2010","journal-title":"J Bacteriol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-2958.2012.08100.x","article-title":"<italic>Chlamydia<\/italic> co-opts the rod shape-determining proteins MreB and Pbp2 for cell division","volume":"85","author":"SP Ouellette","year":"2012","journal-title":"Mol Microbiol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1128\/JB.180.7.1831-1840.1998","article-title":"Acquisition of five high-Mr penicillin-binding protein variants during transfer of high-level beta-lactam resistance from <italic>Streptococcus mitis<\/italic> to <italic>Streptococcus pneumoniae<\/italic>","volume":"180","author":"R Hakenbeck","year":"1998","journal-title":"J Bacteriol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/jac\/dkf140","article-title":"A change in PBP1 is involved in amoxicillin resistance of clinical isolates of <italic>Helicobacter pylori<\/italic>","volume":"50","author":"T Okamoto","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1046\/j.0306-5251.2001.01435.x","article-title":"Effect of acid secretion blockade by omeprazole on the relative bioavailability of orally administered furazolidone in healthy volunteers","volume":"52","author":"SA Calafatti","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1128\/IAI.00524-10","article-title":"Invasion and multiplication of <italic>Helicobacter pylori<\/italic> in gastric epithelial cells and implications for antibiotic resistance","volume":"78","author":"YT Chu","year":"2010","journal-title":"Infect Immun"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4161\/auto.5.4.8167","article-title":"When <italic>Helicobacter pylori<\/italic> invades and replicates in the cells","volume":"5","author":"YH Wang","year":"2009","journal-title":"Autophagy"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1128\/JB.01416-08","article-title":"The complete genome sequence of <italic>Helicobacter pylori<\/italic> strain G27","volume":"191","author":"DA Baltrus","year":"2009","journal-title":"J Bacteriol"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"10646","DOI":"10.1073\/pnas.0504927102","article-title":"Activation of beta-catenin by carcinogenic <italic>Helicobacter pylori<\/italic>","volume":"102","author":"AT Franco","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"9999","DOI":"10.1073\/pnas.0603784103","article-title":"The complete genome sequence of a chronic atrophic gastritis <italic>Helicobacter pylori<\/italic> strain: evolution during disease progression","volume":"103","author":"JD Oh","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0016-5085(97)70155-0","article-title":"A standardized mouse model of <italic>Helicobacter pylori<\/italic> infection: introducing the Sydney strain","volume":"112","author":"A Lee","year":"1997","journal-title":"Gastroenterology"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/16495","article-title":"Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen <italic>Helicobacter pylori<\/italic>","volume":"397","author":"RA Alm","year":"1999","journal-title":"Nature"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/41483","article-title":"The complete genome sequence of the gastric pathogen <italic>Helicobacter pylori<\/italic>","volume":"388","author":"JF Tomb","year":"1997","journal-title":"Nature"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0068917","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T19:28:01Z","timestamp":1596223681000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0068917"}},"subtitle":[],"editor":[{"given":"Asad\u00a0U","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,25]]},"references-count":74,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0068917","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,25]]}}}